Sign inGet started

ARPO

Aerpio Pharmaceuticals, Inc.CIK 1422142 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17

AI insights for ARPO PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for ARPO
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Dugel PravinDirector7$0$02021-06-30
Dalal AnupamDirector6$0$02021-06-30
Cohen CherylDirector7$0$02021-06-30
Castelein CaleyDirector8$0$02021-06-30
Prelack StevenDirector5$0$02021-06-30
OrbiMed Capital GP V LLC10% Owner3$0$41.9K2020-12-08
Marek ReginaVice President of Finance2$0$02020-03-16
Gardner Joseph H.President7$8.6K$02020-03-16
PETERS KEVIN G.See Remarks5$0$02020-03-16
Khuong Chau QuangDirector, 10% Owner3$2.99M$02019-06-18
Satter Muneer ADirector, 10% Owner34$8.19M$02019-06-18
ROGERS MICHAEL WSee Remarks5$0$02019-05-14
HOFFMAN STEPHEN JChief Executive Officer6$64.1K$02019-05-14
NOVARTIS AG10% Owner9$0$1.11M2019-04-26
Novartis Bioventures Ltd10% Owner12$0$684.9K2019-04-15
PAKOLA STEVEChief Medical Officer2$0$02019-02-15
ORBIMED ADVISORS LLCDirector, 10% Owner1$2.99M$02018-06-28

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Cohen CherylDirector A Award2021-06-302021-07-028,140$1.52 $12.4K16,160SEC↗
Castelein CaleyDirector A Award2021-06-302021-07-027,811$1.52 $11.9K295,414SEC↗
Dugel PravinDirector A Award2021-06-302021-07-026,331$1.52 $9.6K12,568SEC↗
Prelack StevenDirector A Award2021-06-302021-07-0212,334$1.52 $18.7K24,485SEC↗
Dalal AnupamDirector A Award2021-06-302021-07-027,400$1.52 $11.2K16,959SEC↗
Cohen CherylDirector A Award deriv2021-06-172021-06-22100,000— $0100,000SEC↗
Prelack StevenDirector A Award2021-03-312021-04-0212,151$1.54 $18.7K12,151SEC↗
Castelein CaleyDirector A Award2021-03-312021-04-027,696$1.54 $11.9K287,603SEC↗
Dalal AnupamDirector A Award2021-03-312021-04-027,290$1.54 $11.2K9,559SEC↗
Dugel PravinDirector A Award2021-03-312021-04-026,237$1.54 $9.6K6,237SEC↗
Cohen CherylDirector A Award2021-03-312021-04-028,020$1.54 $12.4K8,020SEC↗
Dalal AnupamDirector A Award deriv2021-02-012021-02-0317,857— $017,857SEC↗
Castelein CaleyDirector A Award deriv2021-02-012021-02-0317,857— $017,857SEC↗
Cohen CherylDirector A Award deriv2021-02-012021-02-0317,857— $017,857SEC↗
Dugel PravinDirector A Award deriv2021-02-012021-02-0317,857— $017,857SEC↗
OrbiMed Capital GP V LLC10% Owner X Exercise deriv2020-12-082020-12-1021,400— $00SEC↗
OrbiMed Capital GP V LLC10% Owner S Sale2020-12-082020-12-1021,400$1.96 $41.9K0SEC↗
OrbiMed Capital GP V LLC10% Owner X Exercise2020-12-082020-12-1021,400$0.96 $20.5K21,400SEC↗
Cohen CherylDirector A Award deriv2020-06-242020-06-2652,144— $052,144SEC↗
Prelack StevenDirector A Award deriv2020-06-242020-06-2652,144— $052,144SEC↗
Castelein CaleyDirector A Award deriv2020-06-242020-06-2652,144— $052,144SEC↗
Dalal AnupamDirector A Award deriv2020-06-242020-06-2652,144— $052,144SEC↗
Dugel PravinDirector A Award deriv2020-06-242020-06-2652,144— $052,144SEC↗
Marek ReginaVice President of Finance A Award deriv2020-03-162020-03-1893,000— $093,000SEC↗
PETERS KEVIN G.See Remarks A Award deriv2020-03-162020-03-18129,000— $0129,000SEC↗
Gardner Joseph H.President A Award deriv2020-03-162020-03-18155,000— $0155,000SEC↗
Marek ReginaVice President of Finance A Award deriv2019-11-042019-11-0644,300— $044,300SEC↗
Gardner Joseph H.President P Buy2019-07-102019-07-105,000$0.81 $4.1K453,019SEC↗
Gardner Joseph H.President P Buy2019-07-032019-07-085,000$0.90 $4.5K448,019SEC↗
Prelack StevenDirector A Award deriv2019-06-182019-06-1921,400— $021,400SEC↗
Cohen CherylDirector A Award deriv2019-06-182019-06-1921,400— $021,400SEC↗
Dugel PravinDirector A Award deriv2019-06-182019-06-1921,400— $021,400SEC↗
Satter Muneer ADirector, 10% Owner A Award deriv2019-06-182019-06-1921,400— $021,400SEC↗
Khuong Chau QuangDirector, 10% Owner A Award deriv2019-06-182019-06-1921,400— $021,400SEC↗
Castelein CaleyDirector A Award deriv2019-06-182019-06-1921,400— $021,400SEC↗
Dalal AnupamDirector A Award deriv2019-06-182019-06-1921,400— $021,400SEC↗
PETERS KEVIN G.See Remarks A Award deriv2019-05-142019-05-1663,250— $063,250SEC↗
PETERS KEVIN G.See Remarks A Award deriv2019-05-142019-05-16266,550— $0266,550SEC↗
ROGERS MICHAEL WSee Remarks A Award deriv2019-05-142019-05-16169,500— $0169,500SEC↗
ROGERS MICHAEL WSee Remarks A Award deriv2019-05-142019-05-16430,500— $0430,500SEC↗
Gardner Joseph H.President A Award deriv2019-05-142019-05-16349,350— $0349,350SEC↗
HOFFMAN STEPHEN JChief Executive Officer A Award deriv2019-05-142019-05-16709,050— $0709,050SEC↗
NOVARTIS AG10% Owner S Sale2019-04-262019-04-29138,704$1.03 $142.9K4,049,804SEC↗
NOVARTIS AG10% Owner S Sale2019-04-252019-04-29563,096$1.03 $580.0K4,188,508SEC↗
NOVARTIS AG10% Owner S Sale2019-04-242019-04-2416,403$1.03 $16.9K4,751,604SEC↗
NOVARTIS AG10% Owner S Sale2019-04-232019-04-2427,554$1.03 $28.4K4,768,007SEC↗
NOVARTIS AG10% Owner S Sale2019-04-222019-04-247,100$0.97 $6.9K4,795,561SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-152019-04-1528,794$0.99 $28.5K4,802,661SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-122019-04-1530,908$1.04 $32.1K4,831,455SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-112019-04-1557,438$1.08 $62.0K4,862,363SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-102019-04-10140,230$1.09 $152.9K4,919,801SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-092019-04-1032,991$1.01 $33.3K5,060,031SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-082019-04-1027,525$1.02 $28.1K5,093,022SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-052019-04-0524,661$1.02 $25.2K5,120,547SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-042019-04-0547,900$1.01 $48.4K5,145,208SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-032019-04-0558,033$0.96 $55.7K5,193,108SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-022019-04-0251,754$0.97 $50.2K5,251,141SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-04-012019-04-02116,909$0.95 $111.1K5,302,895SEC↗
Novartis Bioventures Ltd10% Owner S Sale2019-03-292019-04-0263,100$0.91 $57.4K5,419,804SEC↗
NOVARTIS AG10% Owner S Sale2019-03-282019-03-2888,835$0.94 $83.5K5,482,904SEC↗
NOVARTIS AG10% Owner S Sale2019-03-272019-03-2850,749$0.99 $50.2K5,571,739SEC↗
NOVARTIS AG10% Owner S Sale2019-03-262019-03-28177,762$1.01 $179.5K5,622,488SEC↗
ROGERS MICHAEL WChief Financial Officer A Award deriv2019-02-152019-02-20215,328— $0215,328SEC↗
PETERS KEVIN G.Chief Scientific Officer A Award deriv2019-02-152019-02-20125,000— $0125,000SEC↗
HOFFMAN STEPHEN JChief Executive Officer A Award deriv2019-02-152019-02-20365,000— $0365,000SEC↗
Gardner Joseph H.President A Award deriv2019-02-152019-02-20150,000— $0150,000SEC↗
PAKOLA STEVEChief Medical Officer A Award deriv2019-02-152019-02-20125,000— $0125,000SEC↗
Satter Muneer ADirector, 10% Owner P Buy2019-01-102019-01-1023,818$2.45 $58.4K5,621,835SEC↗
Satter Muneer ADirector, 10% Owner P Buy2019-01-092019-01-1020,000$2.39 $47.8K5,598,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2019-01-082019-01-1020,000$2.20 $44.0K5,578,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2019-01-072019-01-0720,000$2.18 $43.6K5,558,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2019-01-042019-01-0720,000$2.12 $42.4K5,538,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2019-01-032019-01-0720,000$2.08 $41.6K5,518,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2019-01-022019-01-0220,000$1.94 $38.8K5,498,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-312019-01-0220,000$1.75 $35.0K5,478,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-282019-01-0220,000$1.72 $34.4K5,458,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-272018-12-2720,000$1.67 $33.4K5,438,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-262018-12-2720,000$1.69 $33.8K5,418,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-212018-12-2720,000$1.84 $36.8K5,398,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-202018-12-2020,000$1.85 $37.0K5,378,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-192018-12-2020,000$1.92 $38.4K5,358,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-182018-12-2020,000$1.99 $39.8K5,338,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-142018-12-1420,000$2.00 $40.0K5,318,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-132018-12-1420,000$2.02 $40.4K5,298,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-122018-12-1420,000$2.05 $41.0K5,278,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-112018-12-1120,000$2.09 $41.8K5,258,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-102018-12-1120,000$2.13 $42.6K5,238,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-072018-12-1120,000$2.14 $42.8K5,218,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-062018-12-0620,000$2.18 $43.6K5,198,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-042018-12-0620,000$2.10 $42.0K5,178,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-12-032018-12-0620,000$1.99 $39.8K5,158,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-11-302018-11-3020,000$1.98 $39.6K5,138,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-11-292018-11-3020,000$2.01 $40.2K5,118,017SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-11-282018-11-3020,000$1.94 $38.8K5,098,017SEC↗
HOFFMAN STEPHEN JChief Executive Officer P Buy2018-11-122018-11-1430,000$2.01 $60.3K31,967SEC↗
HOFFMAN STEPHEN JChief Executive Officer P Buy2018-11-092018-11-141,967$1.95 $3.8K1,967SEC↗
Dugel PravinDirector A Award deriv2018-10-262018-11-162,500— $02,500SEC↗
Castelein CaleyDirector J Other2018-09-242018-09-26268,987— $0279,907SEC↗
Castelein CaleyDirector D To issuer2018-09-242018-09-261,603,526— $00SEC↗
NOVARTIS AG10% Owner S Sale2018-08-202018-08-225,300$3.90 $20.7K5,800,250SEC↗
Khuong Chau QuangDirector, 10% Owner P Buy2018-06-282018-07-02777,500$3.85 $2.99M5,193,946SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner P Buy2018-06-282018-07-02777,500$3.85 $2.99M5,193,946SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-06-282018-06-291,818,182$3.85 $7.00M5,078,017SEC↗
Cohen CherylDirector A Award deriv2018-06-202018-06-2242,800— $042,800SEC↗
Castelein CaleyDirector A Award deriv2018-06-202018-06-2221,400— $021,400SEC↗
Prelack StevenDirector A Award deriv2018-06-202018-06-2221,400— $021,400SEC↗
Dugel PravinDirector A Award deriv2018-06-202018-06-2221,400— $021,400SEC↗
Khuong Chau QuangDirector A Award deriv2018-06-202018-06-2221,400— $021,400SEC↗
Dalal AnupamDirector A Award deriv2018-06-202018-06-2221,400— $021,400SEC↗
Satter Muneer ADirector, 10% Owner A Award deriv2018-06-202018-06-2221,400— $021,400SEC↗
Gardner Joseph H.President A Award deriv2018-04-232018-04-25150,000— $0150,000SEC↗
PAKOLA STEVEChief Medical Officer A Award deriv2018-04-232018-04-25100,000— $0100,000SEC↗
ROGERS MICHAEL WChief Financial Officer A Award deriv2018-04-232018-04-25144,000— $0144,000SEC↗
PETERS KEVIN G.Chief Scientific Officer A Award deriv2018-04-232018-04-25100,000— $0100,000SEC↗
HOFFMAN STEPHEN JChief Executive Officer A Award deriv2018-04-232018-04-25300,000— $0300,000SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-03-232018-03-231,000$5.00 $5.0K3,259,835SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-03-212018-03-234,000$4.85 $19.4K3,258,835SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-03-202018-03-215,400$4.97 $26.8K3,254,835SEC↗
Satter Muneer ADirector, 10% Owner P Buy2018-03-192018-03-217,600$4.96 $37.7K3,249,435SEC↗
ROGERS MICHAEL WChief Financial Officer A Award deriv2017-12-142017-12-18293,006$5.50 $1.61M0SEC↗
Gardner Joseph H.President A Award deriv2017-12-142017-12-18135,000$5.50 $742.5K0SEC↗
HOFFMAN STEPHEN JChief Executive Officer A Award deriv2017-12-142017-12-18586,012$5.50 $3.22M0SEC↗